Article
type: Class

Document
type: Class

Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data
most specific type: Academic Article
type: Entity
type: Information Content Entity
type: Generically Dependent Continuant
language: Inglese
type: Thing
type: Academic Article
type: Article
type: Document
type: Continuant

Information Content Entity
type: Class

Academic Article
type: Class

Continuant
type: Class

Inglese
type: Language

Entity
type: Class

Generically Dependent Continuant
type: Class

RDF description of Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data - http://irises.unibs.it/resource/item/175542
rights: termsOfUse
date: 2026-08-25T22:11:00
publisher: Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data
type: Document